Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

choles

Battling misinformation on the world’s biggest killer

August 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cardiovascular disease, cholesterol, healthcare, heart disease, heart failure, medicine, pharma, pharmaceutical

Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of …
Feature

Takeda strikes partnership to develop single-drug cancer combo immunotherapies

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, immunotherapy, medicine, pharma, pharmaceuticals

Japanese pharma giant Takeda has announced that it is to partner up with US-based Shattuck Labs in a collaboration to …
News
shutterstock_95714119

Over 1,000 currently active cancer trials spell trouble for patient recruitment

August 14, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, drugs, life sciences, medicine, pharma, pharmaceutical

The number of active clinical trials in the cancer space has reached more than 1,000 and rising, outstripping the number …
News
brain-1787622_640

Early-stage study gives hope for rare and fatal neurodegenerative condition

August 11, 2017 Medical Communications, Research and Development biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical

A team of researchers at Washington University School of Medicine (WUSM) in St Louis and the Eunice Kennedy Shriver National …
News
shutterstock_87495637

Ending the era of $100,000 cancer drugs

August 11, 2017 Medical Communications, Research and Development Cancer, biotech, drugs, healthcare, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

August 11, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Merck, NICE, Parkinson's, biotech, diabetes, pharma, pharmaceutical, top ten

Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …
News
heart-2372134_640

Heart failure mortality rates fall across England and Wales, national audit finds

August 11, 2017 Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical

Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …
News
continuous_manufacturing2

Continuous manufacturing: Upgrading the supply chain to meet rising demand

August 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing continuous manufacturing, life sciences, manufacturing, medicine, pharma, pharmaceutical

Pharmaceutical production has long been the object of scrutiny to ensure the highest levels of quality and safety are maintained. …
Feature
cancer-vs-alzheimer-1080x810

Cancer Research UK partners with Biotecnol to deliver experimental solid tumour drug

August 10, 2017 Research and Development, Sales and Marketing Biotecnol, Cancer, Cancer Research UK, drugs, immunotherapy, life sciences, medicine, pharma, pharmaceutical

Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …
News

Pioneering immunotherapy halts progression of type 1 diabetes

August 10, 2017 Research and Development Type 1 diabetes, diabetes, drugs, insulin, life sciences, medicines, pharma, pharmaceutical

In a first for the disease area, an immunotherapy treatment for diabetes, developed by researchers at King’s College London and …
News
rasmus-web

Alvotech recruit new CEO from within

August 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alvotech, biotech, drugs, pharma, pharmaceutical

Alvotech, a biopharmaceutical company focusing on the development and manufacture of based in Reykjavik, Iceland, has replaced outgoing CEO, Eef …
Appointment
shutterstock_38078521

FDA awards orphan status to new brain cancer vaccine

August 9, 2017 Research and Development, Sales and Marketing FDA, life sciences, orphan drug, pharma, pharmaceuticals

The FDA has announced that it has awarded orphan drug status to the vaccine SurVaxM for patients with glioblastoma, the …
News
valeant

Valeant focused on bringing new products to market, receives CRL

August 9, 2017 Research and Development, Sales and Marketing Valeant, biotech, drugs, pharma, pharmaceutical

In its second quarter financial reports, Valeant strove to strike a positive note. It revealed that it had paid down …
News
800px-cancer_cells_1

Chemotherapy can spread breast cancer to lungs, study finds

August 9, 2017 Research and Development Cancer, breast cancer, life sciences, lung cancer, pharma, pharmaceutical

Researchers at Ohio State University have discovered that, as well as forming a key part of treatment strategies to fight …
News
injection-2248377_960_720

Global shortage of hep B vaccine hits UK

August 9, 2017 Manufacturing and Production, Research and Development GSK, MSD, biotech, drugs, hep b, hepatitis B, pharma, pharmaceutical

Only last week it was revealed that the UK would administer all babes with the hepatitis B vaccine to reduce …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026